Xavier M. Keutgen, MD
Xavier M. Keutgen, MD
Associate Professor of Surgery
Associate Professor of Radiation and Cellular Oncology
Specialties
- Endocrine Surgery
- General Surgery
- Surgical Oncology
Locations
- Chicago - Hyde Park
Schedule an Appointment
Schedule an Appointment- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Xavier M. Keutgen, MD, is an endocrine and neuroendocrine surgeon with particular expertise in treating thyroid, parathyroid, adrenal and neuroendocrine tumors. Dr. Keutgen is the director of the University of Chicago Medicine Neuroendocrine Tumor Center and works closely with a multidisciplinary team that specializes in NETs. He is the co-director of the Von Hippel-Lindau (VHL) Clinical Care Center and a member of the multidisciplinary thyroid cancer team at the University of Chicago.
When surgery is indicated, Dr. Keutgen uses minimally invasive approaches whenever possible. He performs small- or no-scar thyroid and parathyroid surgery, thyroid nodule radiofrequency ablations as well as laparoscopic pancreas, liver and adrenal surgery. Dr. Keutgen also specializes in complex liver resections for metastatic neuroendocrine tumors of the gastrointestinal (GI) tract and pancreas. He is one of the few surgeons in the country with advanced expertise in extensive removal of neuroendocrine liver tumors metastases (“debulking surgery”) using techniques that preserve a maximal amount of normal liver tissue (parenchymal sparing liver surgery).
Dr. Keutgen has a broad interest in basic science, translational and clinical research of endocrine neoplasms, with a particular focus on neuroendocrine tumors. His laboratory research focuses on understanding DNA pathway repair choice and increasing radiosensitivity of neuroendocrine tumors, identifying molecular mechanisms that are responsible for endocrine tumor formation and discovery of novel methods to inhibit tumor growth. In addition, Dr. Keutgen is also part of a research team that investigates the use of artificial intelligence to diagnose thyroid cancer with ultrasound images.
Dr. Keutgen is the lead investigator on several clinical trials that focus on new diagnostic and therapeutic methods for endocrine and neuroendocrine tumors. His clinical and laboratory research have been published in Clinical Cancer Research, Cancer, Gastroenterology, Annals of Surgery, Surgery, JACS, Modern Pathology, JCEM and Nature Reviews Clinical Oncology, amongst others, and has been funded by the American Association of Endocrine Surgeons, the North American Neuroendocrine Tumor Foundation, the Cancer Research Foundation and several NIH subawards.
Specialties
- Endocrine Surgery
- General Surgery
- Surgical Oncology
Areas of Expertise
- Neuroendocrine Tumors
- Endocrine Cancers
- Adrenal Tumors
- Thyroid Cancer
- Endocrine Cancer Surgery
- Parathyroid Cancer
- Liver Cancer
- Pancreatic Cancer
- Von Hippel-Lindau Disease
- Hyperparathyroidism
Board Certifications
- Surgery
Practicing Since
- 2013
Languages Spoken
- English
- French
- German
Medical Education
- University of Heidelberg Medical School
Internship
- New York-Presbyterian Hospital
Residency
- New York-Presbyterian Hospital
Fellowship
- MD Anderson Cancer Center; National Cancer Insitute; University Hospital Zurich
Memberships & Medical Societies
- American Association for Cancer Research
- American Association of Endocrine Surgeons
- American College of Surgeons
- American Thyroid Association
- Americas Hepato-Pancreato-Biliary Association
- Association for Academic Surgery
- North American Neuroendocrine Tumor Society
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
*Click Here to visit our insurance page and learn more.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.